trending Market Intelligence /marketintelligence/en/news-insights/trending/RfGZV1qyCodbwY22Ib1-Dg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Novartis' Alcon unit acquires US lens implant maker PowerVision

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Novartis' Alcon unit acquires US lens implant maker PowerVision

Novartis AG's Alcon Inc. acquired U.S. medical device company PowerVision Inc. for $285 million.

PowerVision is a privately held company focused on creating fluid-based intraocular lens implants, which restores the vision of people affected by cataracts and/or presbyopia, the eyes' inability to focus up close.

Alcon, the eye care division being spun out of Swiss drugmaker Novartis, will make additional payments to PowerVision upon achievement of certain regulatory and commercial milestones starting in 2023. The acquisition does not have any effect on Alcon's 2023 financial guidance.

PowerVision's intraocular lens technology will be commercially available after significant additional development and clinical trials, Alcon said.